LianBio Announces Presentation of Data from Phase 2a Study o

LianBio Announces Presentation of Data from Phase 2a Study of Infigratinib in Patients with Gastric Cancer at ESMO Congress 2023

LianBio Announces Presentation of Data from Phase 2a Study of Infigratinib in Patients with Gastric Cancer at ESMO Congress 2023

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Macau , Jiajia Yuan , Gansu , Hong Kong , Shanghai , Peking , Beijing , Chinese , Katherine Smith , Bio Pharma , Yizhe Wang , Elizabeth Anderson , Josh Xu , Vp Communications , China National Medical Products Administration , Exchange Commission , University Cancer Hospital , European Society For Medical Oncology , Bio Announces Presentation , Gastric Cancer , Peking University Cancer Hospital , Medical Oncology , Locally Advanced , Metastatic Gastric Cancer , Gastroesophageal Junction Adenocarcinoma , Chief Executive Officer , Breakthrough Therapy Designation , Bridgebio Pharma , Mainland China , Annual Report , Investor Relations , Evoke Canale ,